Role of Toll-like receptor 2 in innate resistance to Group B Streptococcus

Microbial Pathogenesis

Volumn 44, Issue 1, 2008, Pages 43-51

  Asplin, Iain R ^a   Carl, David J ^a   Way, Sing Sing ^a   Jones, Amanda L ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Penicillin binding protein 1a; Streptococcus agalactiae; Toll like receptor 2

Indexed keywords

CYTOKINE; ERYTHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1A; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM POSITIVE BACTERIUM; INNATE IMMUNITY; LD 50; MOUSE; MUTANT; NONHUMAN; PONA GENE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TRANSPOSON;

ANIMALS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INTERLEUKIN-6; MICE; MUTATION; STREPTOCOCCUS AGALACTIAE; SURVIVAL ANALYSIS; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

MUS; POSIBACTERIA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 37049039705     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.08.001     Document Type: Article

References (48)

1. Baker C.J., and Edwards M.W. Group B Streptococcal infections. In: Remington J.S., Klein J.O., Wilson C.B., and Baker C.J. (Eds). Infectious diseases of the fetus and newborn infant. 6th ed (2005), Elsevier Sanders 1091-1156
2. Schuchat A. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clin Infect Dis 33 (2001) 751-756
3. Mazade M.A., and Edwards M.S. Impairment of type III Group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mol Genet Metab 73 (2001) 259-267
4. Henning K.J., Hall E.L., Dwyer D.M., Billmann L., Schuchat A., Johnson J.A., et al. Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis 183 (2001) 1138-1142
5. Dunne D.W., and Quagliarello V. Group B streptococcal meningitis in adults. Medicine (Baltimore) 72 (1993) 1-10
6. Tyrrell G.J., Senzilet L.D., Spika J.S., Kertesz D.A., Alagaratnam M., Lovgren M., et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis 182 (2000) 168-173
7. Johri A.K., Paoletti L.C., Glaser P., Dua M., Sharma P.K., Grandi G., et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 4 (2006) 932-942
8. Kenzel S., and Henneke P. The innate immune system and its relevance to neonatal sepsis. Curr Opin Infect Dis 19 (2006) 264-270
9. Horng T., Barton G.M., Flavell R.A., and Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420 (2002) 329-333
10. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420 (2002) 324-329
11. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11 (1999) 443-451
12. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
13. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163 (1999) 1-5
14. Yoshimura A., Takada H., Kaneko T., Kato I., Golenbock D., and Hara Y. Structural requirements of muramylpeptides for induction of Toll-like receptor 2-mediated NF-kappaB activation in CHO cells. J Endotoxin Res 6 (2000) 407-410
15. Dziarski R., and Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immun 73 (2005) 5212-5216
16. Chaput C., and Boneca I.G. Peptidoglycan detection by mammals and flies. Microbes Infect 9 (2007) 637-647
17. Inamura S., Fujimoto Y., Kawasaki A., Shiokawa Z., Woelk E., Heine H., et al. Synthesis of peptidoglycan fragments and evaluation of their biological activity. Org Biomol Chem 4 (2006) 232-242
18. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 5 (2004) 1000-1006
19. Henneke P., Morath S., Uematsu S., Weichert S., Pfitzenmaier M., Takeuchi O., et al. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174 (2005) 6449-6455
20. Henneke P., Takeuchi O., van Strijp J.A., Guttormsen H.K., Smith J.A., Schromm A.B., et al. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J Immunol 167 (2001) 7069-7076
21. Jones A.L., Knoll K.M., and Rubens C.E. Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol 37 (2000) 1444-1455
22. Jones A.L., Needham R.H., Clancy A., Knoll K.M., and Rubens C.E. Penicillin-binding proteins in Streptococcus agalactiae: a novel mechanism for evasion of immune clearance. Mol Microbiol 47 (2003) 247-256
23. Jones A.L., Mertz R.H., Carl D.J., and Rubens C.E. A streptococcal penicillin-binding protein is critical for resisting innate airway defenses in the neonatal lung. J Immunol 179 (2007) 3196-3202
24. Hamilton A., Popham D.L., Carl D.J., Lauth X., Nizet V., and Jones A.L. Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides. Infect Immun 74 (2006) 6179-6187
25. Goffin C., and Ghuysen J.M. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev 62 (1998) 1079-1093
26. Popham D.L., and Setlow P. Cloning, nucleotide sequence, and mutagenesis of the Bacillus subtilis ponA operon, which codes for penicillin-binding protein (PBP) 1 and a PBP-related factor. J Bacteriol 177 (1995) 326-335
27. Duez C., Hallut S., Rhazi N., Hubert S., Amoroso A., Bouillenne F., et al. The ponA gene of Enterococcus faecalis JH2-2 codes for a low-affinity class A penicillin-binding protein. J Bacteriol 186 (2004) 4412-4416
28. Born P., Breukink E., and Vollmer W. In vitro synthesis of cross-linked murein and its attachment to sacculi by PBP1A from Escherichia coli. J Biol Chem (2006)
29. Henneke P., Takeuchi O., Malley R., Lien E., Ingalls R.R., Freeman M.W., et al. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 169 (2002) 3970-3977
30. Henneke P., and Berner R. Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect Immun 74 (2006) 3085-3095
31. Way S.S., Thompson L.J., Lopes J.E., Hajjar A.M., Kollmann T.R., Freitag N.E., et al. Characterization of flagellin expression and its role in Listeria monocytogenes infection and immunity. Cell Microbiol 6 (2004) 235-242
32. Beg A.A., Finco T.S., Nantermet P.V., and Baldwin Jr. A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol 13 (1993) 3301-3310
33. Kutuk O., and Basaga H. Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis. Cytokine 25 (2004) 229-237
34. Dillon Jr. H.C., Gray E., Pass M.A., and Gray B.M. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 145 (1982) 794-799
35. Manning S.D., Neighbors K., Tallman P.A., Gillespie B., Marrs C.F., Borchardt S.M., et al. Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis 39 (2004) 380-388
36. Flo T.H., Halaas O., Lien E., Ryan L., Teti G., Golenbock D.T., et al. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 164 (2000) 2064-2069
37. Mancuso G., Midiri A., Beninati C., Biondo C., Galbo R., Akira S., et al. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J Immunol 172 (2004) 6324-6329
38. Lehnardt S., Henneke P., Lien E., Kasper D.L., Volpe J.J., Bechmann I., et al. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol 177 (2006) 583-592
39. Ulevitch R.J., and Tobias P.S. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 11 (1999) 19-22
40. Denome S.A., Elf P.K., Henderson T.A., Nelson D.E., and Young K.D. Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis. J Bacteriol 181 (1999) 3981-3993
41. McPherson D.C., Driks A., and Popham D.L. Two class A high-molecular-weight penicillin-binding proteins of Bacillus subtilis play redundant roles in sporulation. J Bacteriol 183 (2001) 6046-6053
42. McPherson D.C., and Popham D.L. Peptidoglycan synthesis in the absence of class A penicillin-binding proteins in Bacillus subtilis. J Bacteriol 185 (2003) 1423-1431
43. Popham D.L., and Setlow P. Phenotypes of Bacillus subtilis mutants lacking multiple class A high-molecular-weight penicillin-binding proteins. J Bacteriol 178 (1996) 2079-2085
44. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165 (2000) 5392-5396
45. Lancefield R.C., McCarty M., and Everly W.N. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med 142 (1975) 165-179
46. Madoff L.C., Michel J.L., and Kasper D.L. A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun 59 (1991) 204-210
47. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Aderem A., Klebanoff S.J., et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166 (2001) 15-19
48. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., and Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3 (2002) 354-359